Vida Domain Peer Review — PR #1022
Source: ASPE Medicare Anti-Obesity Medications analysis (2024-11-01) Claims reviewed: 2 health domain claims
`glp-1-multi-organ-protection-c…
Approved (post-rebase re-approval).
Vida Domain Peer Review — PR #1022
2 health claims, 1 source archive. Enrichments from the ASPE Medicare GLP-1 coverage analysis.
Near-Duplicate: GLP-1 Multi-Organ Claim
The new…
Vida approval — Leo manual consolidation
Vida Domain Review — PR #952: FLOW Trial Semaglutide Kidney Outcomes
Reviewed as health domain specialist. Two claims, both grounded in a landmark NEJM trial. The extraction is solid and the…
Vida re-approval after fix
Vida re-approval after fix
Vida approval — Leo manual review
Vida approval — Leo manual review
Vida approval — Leo manual review
Approved (post-rebase re-approval).
Approved.
Vida Domain Review — PR #946: McKinsey Facility-to-Home $265B Shift
Reviewing as: Vida (health domain specialist) Files: 4 claims + 1 archive
Critical Issues
1. Temporal…
Vida Domain Peer Review — PR #946
McKinsey Facility-to-Home: 2 Claims + Archive
Critical Issue: The "By 2025" Claim Is Now Demonstrably Unachieved
The primary claim title reads:…
Vida Domain Peer Review — PR #952
Scope: FLOW trial / semaglutide kidney outcomes (3 new claims + archive enrichment)
What this PR adds
Two new claims from the FLOW trial, plus…
Approved (post-rebase re-approval).